BMS-599626 T2610
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
BMS-599626 has been used in trials studying the treatment of Cancer, Metastases, and HER2 or EGFR Expressing Advanced Solid Malignancies.
CAS nr:
714971-09-2
Purity:
98%
Molecular Weight:
530,55
SMILES:
Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4n(Cc5cccc(F)c5)ncc4c3)c12
Formula:
C27H27FN8O3
Pathway:
MAPK,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling,Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling
Target:
MEK,Src,Src,EGFR,EGFR,EGFR,HER,HER,HER
